Intuitive surgical, inc.ISRG.US Overview

US StockHealthcare
(No presentation for ISRG)

ISRG Overall Performance

METRIC
VALUE
vs. INDUSTRY
EPS
7.69
PE Ratio
69.36
Forward PE
59.39
PS Ratio
19.86
PB Ratio
11.25
Price-to-FCF
84.34
Gross Margin
66.38%
Net Margin
28.58%
Revenue Growth (YoY)
22.18%
Profit Growth (YoY)
21.08%
3-Year Revenue Growth
17.17%
3-Year Profit Growth
16.47%

ISRG AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ISRG PowerScanner

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ISRG Key Information

ISRG Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2025Q1
2025Q2
2025Q3
2025Q4
2026Q1

ISRG Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2024Q4
2024Q3
2024Q2
2024Q1

ISRG Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Price of ISRG

ISRG Related Articles

ISRG FAQ

  • When is ISRG's latest earnings report released?

    The most recent financial report for Intuitive surgical, inc. (ISRG) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ISRG's short-term business performance and financial health. For the latest updates on ISRG's earnings releases, visit this page regularly.

  • Where does ISRG fall in the P/E River chart?

    According to historical valuation range analysis, Intuitive surgical, inc. (ISRG)'s current price-to-earnings (P/E) ratio is 68.02, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of ISRG?

    According to the latest financial report, Intuitive surgical, inc. (ISRG) reported an Operating Profit of 759.7M with an Operating Margin of 30.33% this period, representing a growth of 31.6% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ISRG's revenue growth?

    In the latest financial report, Intuitive surgical, inc. (ISRG) announced revenue of 2.51B, with a Year-Over-Year growth rate of 22.91%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does ISRG have?

    At the end of the period, Intuitive surgical, inc. (ISRG) held Total Cash and Cash Equivalents of 2.81B, accounting for 0.15 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ISRG go with three margins increasing?

    In the latest report, Intuitive surgical, inc. (ISRG) achieved the “three margins increasing” benchmark, with a gross margin of 66.4%%, operating margin of 30.33%%, and net margin of 28.1%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ISRG's profit trajectory and future growth potential.

  • Is ISRG's EPS continuing to grow?

    According to the past four quarterly reports, Intuitive surgical, inc. (ISRG)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.98. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ISRG?

    Intuitive surgical, inc. (ISRG)'s Free Cash Flow (FCF) for the period is 735.6M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 60.4% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ISRG?

    The latest valuation data shows Intuitive surgical, inc. (ISRG) has a Price-To-Earnings (PE) ratio of 68.02 and a Price/Earnings-To-Growth (PEG) ratio of 7.44. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.